Emmaus Life Sciences, Inc. (EMMA) income statement
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences, Inc. financial ratios
See a number that looks wrong?